0001209191-22-035075.txt : 20220608 0001209191-22-035075.hdr.sgml : 20220608 20220608170026 ACCESSION NUMBER: 0001209191-22-035075 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220607 FILED AS OF DATE: 20220608 DATE AS OF CHANGE: 20220608 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: TZIANABOS ARTHUR CENTRAL INDEX KEY: 0001586226 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38938 FILM NUMBER: 221004087 MAIL ADDRESS: STREET 1: C/O HOMOLOGY MEDICINES, INC. STREET 2: ONE PATRIOTS PARK CITY: BEDFORD STATE: MA ZIP: 01730 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Stoke Therapeutics, Inc. CENTRAL INDEX KEY: 0001623526 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 471144582 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 45 WIGGINS AVENUE CITY: BEDFORD STATE: MA ZIP: 01730 BUSINESS PHONE: 781-430-8200 MAIL ADDRESS: STREET 1: 45 WIGGINS AVENUE CITY: BEDFORD STATE: MA ZIP: 01730 FORMER COMPANY: FORMER CONFORMED NAME: ASOthera Pharmaceuticals, Inc. DATE OF NAME CHANGE: 20141028 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2022-06-07 0 0001623526 Stoke Therapeutics, Inc. STOK 0001586226 TZIANABOS ARTHUR C/O STOKE THERAPEUTICS, INC. 45 WIGGINS AVENUE BEDFORD MA 01730 1 0 0 0 Director Stock Option (Right to Buy) 12.96 2022-06-07 4 A 0 21000 0.00 A 2032-06-06 Common Stock 21000 21000 D The option shall vest on June 7, 2023 or, if earlier, the next annual meeting of the issuer's stockholders, subject to the reporting holder's continued service on such vesting date. /s/ Stephen Tulipano, Attorney-in-Fact 2022-06-08